212 related articles for article (PubMed ID: 22414916)
1. Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods.
Poirel L; Bonnin RA; Nordmann P
Infect Genet Evol; 2012 Jul; 12(5):883-93. PubMed ID: 22414916
[TBL] [Abstract][Full Text] [Related]
2. Genetic support of extended-spectrum beta-lactamases.
Poirel L; Naas T; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():75-81. PubMed ID: 18154530
[TBL] [Abstract][Full Text] [Related]
3. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
4. IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons.
Zhao WH; Hu ZQ
Crit Rev Microbiol; 2011 Aug; 37(3):214-26. PubMed ID: 21707466
[TBL] [Abstract][Full Text] [Related]
5. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
Bradford PA
Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance integrons and extended-spectrum {beta}-lactamases among Enterobacteriaceae isolates recovered from chickens and swine in Portugal.
Machado E; Coque TM; Cantón R; Sousa JC; Peixe L
J Antimicrob Chemother; 2008 Aug; 62(2):296-302. PubMed ID: 18456652
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of extended-spectrum beta-lactamases in South America.
Villegas MV; Kattan JN; Quinteros MG; Casellas JM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
[TBL] [Abstract][Full Text] [Related]
10. Acquired metallo-β-lactamases and their genetic association with class 1 integrons and ISCR elements in Gram-negative bacteria.
Zhao WH; Hu ZQ
Future Microbiol; 2015; 10(5):873-87. PubMed ID: 26000655
[TBL] [Abstract][Full Text] [Related]
11. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
Walsh TR
Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of β-lactamase production in Gram-negative bacteria from Saudi Arabia.
Yezli S; Shibl AM; Memish ZA
J Med Microbiol; 2015 Feb; 64(Pt 2):127-136. PubMed ID: 25418734
[TBL] [Abstract][Full Text] [Related]
13. [Beta-lactamases of Gram negative bacteria: never-ending clockwork!].
Philippon A; Arlet G
Ann Biol Clin (Paris); 2006; 64(1):37-51. PubMed ID: 16420989
[TBL] [Abstract][Full Text] [Related]
14. Metallo-beta-lactamases: the quiet before the storm?
Walsh TR; Toleman MA; Poirel L; Nordmann P
Clin Microbiol Rev; 2005 Apr; 18(2):306-25. PubMed ID: 15831827
[TBL] [Abstract][Full Text] [Related]
15. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
16. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
Martínez-Martínez L; Calvo J
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927
[TBL] [Abstract][Full Text] [Related]
17. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
Lee JH; Bae IK; Lee SH
Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973
[TBL] [Abstract][Full Text] [Related]
18. Evolution of extended-spectrum beta-lactamases by mutation.
Gniadkowski M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():11-32. PubMed ID: 18154525
[TBL] [Abstract][Full Text] [Related]
19. Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.
Brasme L; Nordmann P; Fidel F; Lartigue MF; Bajolet O; Poirel L; Forte D; Vernet-Garnier V; Madoux J; Reveil JC; Alba-Sauviat C; Baudinat I; Bineau P; Bouquigny-Saison C; Eloy C; Lafaurie C; Siméon D; Verquin JP; Noël F; Strady C; De Champs C
J Antimicrob Chemother; 2007 Nov; 60(5):956-64. PubMed ID: 17804424
[TBL] [Abstract][Full Text] [Related]
20. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
